{"name": "REPLICEL LIFE SCIENCES",
 "permalink": "replicel-life-sciences",
 "crunchbase_url": "http://www.crunchbase.com/company/replicel-life-sciences",
 "homepage_url": "http://replicel.com",
 "blog_url": "",
 "blog_feed_url": "http://feeds.feedburner.com/replicel",
 "twitter_username": "RepliCel",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "604-248-8730",
 "description": "",
 "created_at": "Thu May 30 12:27:45 UTC 2013",
 "updated_at": "Thu May 30 12:27:45 UTC 2013",
 "overview": "\u003Cp\u003ERepliCel\u2019s current research activity is focused on the company\u2019s core understanding of the unique biological function of hair follicle cells. Two distinct autologous cell therapies are currently in development. The first is a cellular treatment for androgenetic alopecia (pattern baldness) named RepliCel Hair-01 (RCH-01). The second is a cell therapy for the treatment of chronic tendon injuries named RepliCel Tendon-01 (RCT-01).\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       79],
      "assets/images/resized/0026/9227/269227v1-max-150x150.png"],
     [[249,
       132],
      "assets/images/resized/0026/9227/269227v1-max-250x250.png"],
     [[249,
       132],
      "assets/images/resized/0026/9227/269227v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO, President \u0026 Director",
    "person":
     {"first_name": "David",
      "last_name": "Hall",
      "permalink": "david-hall-3",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$70.2k",
 "funding_rounds":
  [{"round_code": "seed",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1205059/000108503713000042/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 70210.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 19,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "SUITE 2020 - 401 WEST GEORGIA STREET",
    "address2": "",
    "zip_code": "V6B 5A1",
    "city": "BRITISH COLUMBIA",
    "state_code": null,
    "country_code": "CAN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        79],
       "assets/images/resized/0026/9226/269226v1-max-150x150.png"],
      [[250,
        132],
       "assets/images/resized/0026/9226/269226v1-max-250x250.png"],
      [[450,
        238],
       "assets/images/resized/0026/9226/269226v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}